Geometry.Net - Health_Conditions: Hepatic Encephalopathy


Home - Health_Conditions - Hepatic Encephalopathy

e99.com Bookstore

Images

Newsgroups

81-95 of 95 Back | 1 | 2 | 3 | 4 | 5

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Hepatic Encephalopathy: more books (47)

Hepatic Encephalopathy: Syndromes and Therapies by Harold O. Conn, 1994-01

Hepatic Encephalopathy by Alan H. Lockwood, 1992-11

Cirrhosis, Hepatic Encephalopathy and Ammonium Toxicity (Advances in Experimental Medicine and Biology)

Hepatic Encephalopathy in Chronic Liver Failure

Hepatic Encephalopathy - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References by ICON Health Publications, 2004-10-04

Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy (Advances in Experimental Medicine and Biology)

Advances in Hepatic Encephalopathy and Metabolic Nitrogen Exchange by Livio Capocaccia, Manuela Merli, et all 1994-12-27

Advances in Cirrhosis, Hyperammonemia, and Hepatic Encephalopathy (Advances in Experimental Medicine and Biology)

Hepatic Encephalopathy: Management With Lactulose and Related Carbohydrates by Harold O. Conn, 1988-10

Hepatic Encephalopathy and Nitrogen Metabolism

Hepatic Encephalopathy, Hyperammonemia and Toxicity (Advances in Experimental Medicine and Biology)

Hepatic Encephalopathy: Pathophysiology and Treatment (Experimental Biology and Medicine) by Roger F. Butterworth, Gilles Pomier Layrargues, 1989-10-01

Progress in Hepatic Encephalo & Metabolic Nitrogen by Bengt Jeppsson, Finn Bengtsson, 1991-04-24

Encephalopathy and Nitrogen Metabolism in Liver Failure

lists with details

INDICES Sorbitol For Hepatic Encephalopathy
INDICES sorbitol for hepatic encephalopathy. Subject INDICES sorbitol for hepaticencephalopathy; From Melanie Beaton melabeat@rph.health.wa.gov.au ;
http://www.essentialdrugs.org/indices/hma/indices.199811/msg00009.php
Article Status 2001
issue. 2001, 12, 17.1.01, hepatic encephalopathy syndromes, Withdrawn. Withdrawn.2001, 14, 17.1.01, Newer aspects hepatic encephalopathy, Withdrawn.
http://www.indianjgastro.com/statuscheck_jan.htm

Extractions: Next>> Year Number Date of receipt Title Outcome Endoscopic pancreatic...experience Rejected 14.5.01 H. pylori...in Kashmir No response- file closed 10.08.01 Correlation between...portal hypertension Rejected 30.4.01 Colonic intussusception...challenge Published July-Aug 2001 issue Impacted denture...presentation Published July-Aug 2001 issue Comparison of...guinea pigs Published Jan-Feb 2002 issue Laser palliation...cases No response- file closed 10.08.01 Spontaneous perforation...pregnancy Published Sept-Oct 2001 issue Pre and post...associated DU Published Jan-Feb 2002 issue Acute exacerbation...hepatitis B No response- file closed 15.09.01 Strongyloides...anticancer therapy Published July-Aug 2001 issue Hepatic encephalopathy syndromes Withdrawn Interplay of...poto-systemic Withdrawn Newer aspects...hepatic encephalopathy Withdrawn Sporadic intra-abdominal abdomen Withdrawn MR imaging...hepatic encephalopathy Withdrawn Nutritional support...hepatic encephalopathy
Welcome To The Universtity Of South Alabama Gastroenterology Continuing Educatio
Blei AT, Cordoba J. Practice Guidelines hepatic encephalopathy. Am J Gastroenterol2001;9619681975. 1. hepatic encephalopathy is diagnosed by.
http://www.usagiedu.com/encephaldoc.htm

Extractions: GASTROENTEROLOGY LITERATURE REVIEW SESSION October 4, 2001 Blei AT, Cordoba J. Practice Guidelines: Hepatic Encephalopathy. Am J Gastroenterol 2001;96:1968-1975. 1. Hepatic encephalopathy is diagnosed by a. finding a high ammonia level in blood b. finding a high ammonia level in CSF c. excluding other causes of altered mental status in a person with cirrhosis d. finding a normal EEG in a person with cirrhosis and altered mental status e. finding asterixis in a person with cirrhosis and altered mental status True or False 2. Correlation of blood ammonia levels with mental state in cirrhosis is inaccurate, blood levels correlate poorly with brain levels. 3. Constipation can be the trigger factor for hepatic encephalopathy 4. Metronidazole 250mg bid or zinc supplementation may be added to lactulose in patients with recurrent encephalopathy 5. Eradication of H. pylori is recommended to prevent recurrent hepatic encephalopathy 6. The onset of hepatic encephalopathy predicts a 1-yr survival of 40%
ENLmedical.com: Conditions And Concerns: Medical Encyclopedia: Hepatic Encephalo
Table of content. hepatic encephalopathy. Causes and Risks Hepaticencephalopathy is caused by disorders affecting the liver. These
http://www.enlmedical.com/article/000302.htm

Extractions: Hepatic encephalopathy is caused by disorders affecting the liver. These include disorders that reduce liver function (such as cirrhosis or hepatitis ) and conditions where blood circulation bypasses the liver. The exact cause of the disorder is unknown. The liver cannot properly metabolize and detoxify substances in the body. Accumulation of toxic substances causes metabolic abnormalities that lead to damage in the central nervous system (brain and spinal cord). The most common toxic substance is ammonia , which is produced by the body when proteins are digested, but normally is detoxified by the liver. Many other substances also accumulate in the body and damage the nervous system. In people with otherwise stable liver disorders, hepatic encephalopathy may be triggered by episodes of gastrointestinal bleeding, excessive dietary protein , or electrolyte abnormalities (especially decrease in potassium, which may result from vomiting or treatments such as diuretics or paracentesis ). The disorder may also be triggered by any condition that results in
Hepatic Encephalopathy
Spanish hepatic encephalopathy. Causes, incidence, and risk factors Hepaticencephalopathy is caused by disorders affecting the liver. These
http://www.umm.edu/ency/article/000302.htm

Extractions: Toggle English Spanish Overview Symptoms Treatment Prevention Definition: A group of symptoms that may occur when there is damage to the brain and nervous system as a complication of liver disorders, characterized by various neurologic symptoms including changes in reflexes, changes in consciousness , and behavior changes that can range from mild to severe. The liver cannot properly metabolize and detoxify substances in the body. Accumulation of toxic substances causes metabolic abnormalities that lead to damage in the central nervous system (brain and spinal cord). One substance believed to be toxic is ammonia , which is produced by the body when proteins are digested, but normally is detoxified by the liver. Many other substances also accumulate in the body and damage the nervous system.
Health Ency.: Disease: Hepatic Encephalopathy
hepatic encephalopathy. Treatment. hepatic encephalopathy is an acute medicalcondition that may become a medical emergency. Hospitalization is required.
http://www.accessatlanta.com/shared/health/adam/ency/article/000302trt.html

Extractions: The goals of treatment include life support, elimination or treatment of precipitating factors, and removal or neutralization of ammonia and other toxins . Life support including support of breathing or circulation may be required, particularly if coma develops. Cerebral edema (brain swelling ) may occur and may be life-threatening. Precipitating factors must be identified and treated. Gastrointestinal bleeding must be stopped. The intestines must be emptied of blood. Blood breaks down into protein components that are converted to ammonia. Treatment of infections, renal failure, and electrolyte abnormalities (especially potassium) are important.
Health Ency.: Disease: Hepatic Encephalopathy
hepatic encephalopathy. Alternative names Hepatic coma; Encephalopathy hepatic. Prevention. Treatment of liver disorders, particularly
http://www.accessatlanta.com/shared/health/adam/ency/article/000302prv.html

Extractions: Important notice Ency. home Disease H Hepatic encephalopathy Overview Symptoms Treatment Prevention Alternative names: Hepatic coma; Encephalopathy - hepatic Prevention Treatment of liver disorders, particularly when that treatment includes restriction of dietary protein (a primary source of ammonia ), may prevent some cases of hepatic encephalopathy.
VetMedCenter - Consumer - Article Details
Brain Disorder Secondary to Liver Disease (hepatic encephalopathy). UnderstandingYour Pet's Medical Diagnosis What is hepatic encephalopathy?
http://www.vetmedcenter.com/consumer/display.asp?fn=P-MR-M-Nu_5-HepEnceph1XX.xml
Stages Of Hepatic Encephalopathy
The summary for this Chinese (Traditional) page contains characters that cannot be correctly displayed in this language/character set.
http://www.vghtc.gov.tw:8082/ped/teaching/GI/ful hepatitis/sld009.htm
Dr. Clarke Cushing
My kitten has hepatic encephalopathy. What causes this? Category Feline. Theveterinarian suspects hepatic encephalopathy. What is this?
http://www.lclarkecushingvmd.com/showpracfaq.cfm?FAQID=12&Private=0
Felipo's Curriculum
Cirrhosis, hepatic encephalopathy and ammonium toxicity In Advances inExperimental Medicine and Biology. Vol. 272, 1990, Plenum Press. New York.
http://www.ochoa.fib.es/Investigadores/Felipo/felipcuri.htm

Extractions: Vicente Felipo. CURRICULUM VITAE Name: Vicente Felipo Born the 12 of May, 1957 at Tabernes Blanques, Valencia, Spain Married Home address: Rey Don Jaime 2-1-B. Tabernes Blanques, 46016 Valencia. Spain Work address: Instituto de Investigaciones Citologicas Amadeo de Saboya, 4 46010 Valencia Spain Telephone: Fax: email: vfelipo@ochoa.fib.es Chemist, Universtiy of Valencia, Spain, June 1979 Doctor (Ph. D.) in Biochemistry, University of Valencia, October 1983 Possition: EDITORIAL WORK: Member of the Editorial Board of the journals: - Neurochemical Research, 1993 - - Metabolic Brain Disease 1994 - - Analytical Pharmacology 1997 - - International Journal of Molecular Medicine 1997 - Editor of the following books - "Cirrhosis, hepatic encephalopathy and ammonium toxicity" In: Advances in Experimental Medicine and Biology. Vol. 272, 1990, Plenum Press. New York - "Cirrhosis, hyperammonemia and hepatic encephalopathy" In: Advances in Experimental Medicine and Biology. Vol. 341, 1993. Plenum Press, New York. - "Hepatic encephalopathy, hyperammonemia and ammonia toxicity" In: Advances in Experimental Medicine and Biology. Vol. 368, 1995. Plenum Press, New York.
Small Animal Clinical Services
hepatic encephalopathy. hepatic encephalopathy has been recognized in animals withPSS, endstage liver disease, and congenital urea cycle enzyme deficiencies.
http://www.vet.utk.edu/clinical/sacs/shunts_pathophysiology.html

Extractions: Anesthesia and Intensive Care Cardiology Clinical Behavior Science Dermatology ... Radiation Oncology Pathophysiology Karen M. Tobias , DVM, MS, Diplomate ACVS Table of Contents: Information for Pet Owners: FAQs Introduction Pathophysiology Hepatic Encephalopathy ... Printer-friendly version - .pdf 103 KB Clinical signs associated with portosystemic shunts commonly involve the nervous system, gastrointestinal tract, and urinary tract. General clinical signs include poor growth rate, weight loss, fever, and anesthetic or tranquilizer intolerance. Neurologic dysfunction is seen in most animals with PSS and includes lethargy and depression, ataxia, seizures, behavioral changes, and blindness. Head pressing, circling, and development of a head tilt have also been reported. Gastrointestinal clinical abnormalities include anorexia, vomiting, and diarrhea. Some dogs have no apparent signs or present with signs of cystitis or urinary tract obstruction. Many cats have hypersalivation and some have unusual copper colored irises. Hepatic histologic changes in animals with PSS include generalized congestion of central veins and sinusoids, lobular collapse, bile duct proliferation, hypoplasia of intrahepatic portal tributaries, proliferation of small vessels and lymphatics, diffuse fatty infiltration, hepatocellular atrophy, and cytoplasmic vacuolization. These pathology changes can also be seen in dogs with hepatic microvascular dysplasia that do not have single congneital shunts. Pathologic changes may be present in the central nervous system, especially in encephalopathic animals.
Benzodiazepine Receptor Antagonists For Acute And Chronic Hepatic Encephalopathy
All rights reserved. Benzodiazepine receptor antagonists for acute and chronic hepaticencephalopathy (Cochrane Review). AlsNielsen B, Kjaergard LL, Gluud C.
http://www.update-software.com/abstracts/ab002798.htm

Extractions: From The Cochrane Library, Issue 1, 2003 Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy (Cochrane Review) Als-Nielsen B, Kjaergard LL, Gluud C ABSTRACT Order full review View and/or submit comments What's new in this issue Search abstracts ... About The Cochrane Library A substantive amendment to this systematic review was last made on 10 July 2001. Cochrane reviews are regularly checked and updated if necessary. Background: The pathogenesis of hepatic encephalopathy is unknown. It has been suggested that liver failure leads to the accumulation of substances that bind to a receptor-complex in the brain resulting in neural inhibition which may progress to coma. Several trials have assessed benzodiazepine receptor antagonists for hepatic encephalopathy, but the results are conflicting. Objectives: To evaluate the efficacy and safety of benzodiazepine receptor antagonists for patients with acute or chronic hepatic encephalopathy. Search strategy: Eligible trials were identified through The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Controlled Trials Register on The Cochrane Library (Issue 2, 2001), MEDLINE and EMBASE (last searched: June 2001), reference lists of relevant articles, authors of trials, and the pharmaceutical company known to produce benzodiazepine receptor antagonists. Selection criteria: Randomised trials comparing any benzodiazepine receptor antagonist versus placebo or no intervention for hepatic encephalopathy were included, regardless of language or publication status.
Correlation Between Arterial Ammonia And Grade Of Hepatic Encephalopathy
Translate this page Folie 19 von 21 Notizen Hier sehen Sie, dass Schweregrad und arteriellerAmmoniak korrelieren. Es besteht jedoch eine gehörige
http://www.ikp.unibe.ch/lab2/Pp/Pp8/sld019.htm
Correlation Between Arterial Ammonia And Grade Of Hepatic Encephalopathy
Translate this page Correlation between arterial ammonia and grade of hepaticencephalopathy. C. o. m. a. g. r. a. d. e. I. I. I. I.I. I. I. V.
http://www.ikp.unibe.ch/lab2/Pp/Pp8/tsld019.htm

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

81-95 of 95 Back | 1 | 2 | 3 | 4 | 5